Rallybio Corp (RLYB)
1.83
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
1.84
+0.01
(+0.55%)
After-Hours: 20:00
Rallybio Market Cap: 69.20M for May 3, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 03, 2024 | 69.20M |
| May 02, 2024 | 69.20M |
| May 01, 2024 | 71.84M |
| April 30, 2024 | 72.60M |
| April 29, 2024 | 69.95M |
| April 26, 2024 | 64.28M |
| April 25, 2024 | 62.39M |
| April 24, 2024 | 59.74M |
| April 23, 2024 | 65.79M |
| April 22, 2024 | 66.93M |
| April 19, 2024 | 66.55M |
| April 18, 2024 | 63.15M |
| April 17, 2024 | 66.55M |
| April 16, 2024 | 68.06M |
| April 15, 2024 | 69.20M |
| April 12, 2024 | 83.19M |
| April 11, 2024 | 112.68M |
| April 10, 2024 | 61.63M |
| April 09, 2024 | 62.39M |
| April 08, 2024 | 63.15M |
| April 05, 2024 | 61.63M |
| April 04, 2024 | 59.74M |
| April 03, 2024 | 63.15M |
| April 02, 2024 | 64.66M |
| April 01, 2024 | 67.68M |
| Date | Value |
|---|---|
| March 28, 2024 | 69.95M |
| March 27, 2024 | 60.12M |
| March 26, 2024 | 55.58M |
| March 25, 2024 | 56.72M |
| March 22, 2024 | 60.50M |
| March 21, 2024 | 62.01M |
| March 20, 2024 | 63.52M |
| March 19, 2024 | 60.50M |
| March 18, 2024 | 61.63M |
| March 15, 2024 | 61.26M |
| March 14, 2024 | 60.31M |
| March 13, 2024 | 66.36M |
| March 12, 2024 | 63.52M |
| March 11, 2024 | 69.57M |
| March 08, 2024 | 70.71M |
| March 07, 2024 | 70.33M |
| March 06, 2024 | 69.92M |
| March 05, 2024 | 70.11M |
| March 04, 2024 | 74.45M |
| March 01, 2024 | 89.19M |
| February 29, 2024 | 87.87M |
| February 28, 2024 | 83.90M |
| February 27, 2024 | 80.12M |
| February 26, 2024 | 68.03M |
| February 23, 2024 | 64.25M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
47.29M
Minimum
Feb 05 2024
751.84M
Maximum
Aug 05 2021
265.22M
Average
253.76M
Median
Market Cap Benchmarks
| Johnson & Johnson | 359.25B |
| Adial Pharmaceuticals Inc | 6.893M |
| Eliem Therapeutics Inc | 281.49M |
| Alpine Immune Sciences Inc | 4.235B |
| Monogram Orthopaedics Inc | 61.37M |
Market Cap Related Metrics
| Price to Book Value | 0.6517 |
| Price | 1.83 |
| Earnings Yield | -100.1% |